Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
antisense oligonucleotide
benzodiazepines
biogen
biotech
blackstone group
blackstone life sciences
boston
boston blog main
boston top stories
clinical trials
1
×
columbia university
david goldstein
depression
epi4k
epilepsy
essential tremor
investing
kiran reddy
life sciences
major depressive disorder
marcio souza
1
×
national blog main
national top stories
new york blog main
new york top stories
perimenopausal depression
praxis precision medicines
ptc therapeutics
startups
steven petrou
third rock ventures
university of melbourne
1
×
venture capital
What
aims
backed
cause
ceo
drugs
1
×
epilepsy
genes
1
×
genetic
links
marcio
medicines
1
×
mutations
neuro
new
praxis
precision
research
souza
stop
turn
Language
unset
Current search:
drugs
×
medicines
×
" clinical trials "
×
genes
×
" marcio souza "
×
" university of melbourne "
×
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs